These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22856502)

  • 1. Can large gauge core biopsies for high risk benign breast lesions eliminate the need for excisional biopsy: a correlation between breast biopsy and final surgical pathology.
    Richard F; Segna KG; Filiberti E
    Am Surg; 2012 Aug; 78(8):906-8. PubMed ID: 22856502
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques.
    Gisvold JJ; Goellner JR; Grant CS; Donohue JH; Sykes MW; Karsell PR; Coffey SL; Jung SH
    AJR Am J Roentgenol; 1994 Apr; 162(4):815-20. PubMed ID: 8140997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative high-risk lesions of the breast: contribution and limits of US-guided core biopsy.
    Zuiani C; Londero V; Bestagno A; Puglisi F; Di Loreto C; Bazzocchi M
    Radiol Med; 2005; 110(5-6):589-602. PubMed ID: 16437044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stereotactic biopsy for non-palpable breast lesions: evaluation and choice of minimal invasive and excisional biopsy].
    Liu GY; Chen CM; Hu Z; Ling H; Shen KW; Shen ZZ; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1322-4. PubMed ID: 17217817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percutaneous core-needle biopsy of palpable breast tumors. Do we need ultrasound guidance?].
    Lorenzen J; Welger J; Lisboa BW; Riethof L; Grzyska B; Adam G
    Rofo; 2002 Sep; 174(9):1142-6. PubMed ID: 12221573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of core biopsy for screen-detected breast lesions under 10 mm: implications for surgical management.
    Farshid G; Downey P; Pieterse S; Gill PG
    ANZ J Surg; 2017 Sep; 87(9):725-731. PubMed ID: 25776551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous removal of benign mammographic lesions: comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques.
    Jackman RJ; Marzoni FA; Nowels KW
    AJR Am J Roentgenol; 1998 Nov; 171(5):1325-30. PubMed ID: 9798873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpalpable breast microcalcifications: frequency, management, and results of incisional biopsy.
    Homer MJ
    Radiology; 1992 Nov; 185(2):411-3. PubMed ID: 1410347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative clip-marking method for use after 14-gauge large core needle biopsy of the breast.
    Gordon P
    Can Assoc Radiol J; 2004 Apr; 55(2):75-8. PubMed ID: 15131926
    [No Abstract]   [Full Text] [Related]  

  • 10. Open surgical biopsy for nonpalpable mammographic abnormalities: still an option compared with core needle biopsy.
    Hall JA; Murphy DC; Hall BR; Hall KA
    Am J Obstet Gynecol; 1998 Jun; 178(6):1245-50. PubMed ID: 9662308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of failure in removing calcium in microcalcification-only lesions using 11-gauge stereotactic vacuum-assisted breast biopsy.
    Gümüş H; Gümüş M; Devalia H; Mills P; Fish D; Jones P; Uyar A; Sever A
    Diagn Interv Radiol; 2012; 18(4):354-9. PubMed ID: 22477646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
    Fuhrman G; Cederbom G; Champagne J; Farr G; McKinnon W; Bolton J; Ordoyne WK
    J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpalpable breast lesions: stereotactic automated large-core biopsies.
    Parker SH; Lovin JD; Jobe WE; Burke BJ; Hopper KD; Yakes WF
    Radiology; 1991 Aug; 180(2):403-7. PubMed ID: 1648757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The status of mammographically guided fine needle aspiration biopsy of nonpalpable breast lesions.
    Jackson VP
    Radiol Clin North Am; 1992 Jan; 30(1):155-66. PubMed ID: 1732924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy.
    Meyer JE; Smith DN; Lester SC; DiPiro PJ; Denison CM; Harvey SC; Christian RL; Richardson A; Ko WD
    Radiology; 1998 Mar; 206(3):717-20. PubMed ID: 9494490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of needle size for breast biopsy: comparison of 14-, 16-, and 18-gauge biopsy needles.
    Helbich TH; Rudas M; Haitel A; Kohlberger PD; Thurnher M; Gnant M; Wunderbaldinger P; Wolf G; Mostbeck GH
    AJR Am J Roentgenol; 1998 Jul; 171(1):59-63. PubMed ID: 9648764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated large-core needle biopsy of surgically removed breast lesions: comparison of samples obtained with 14-, 16-, and 18-gauge needles.
    Nath ME; Robinson TM; Tobon H; Chough DM; Sumkin JH
    Radiology; 1995 Dec; 197(3):739-42. PubMed ID: 7480748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy.
    Liberman L; Sama MP
    AJR Am J Roentgenol; 2000 Jul; 175(1):53-8. PubMed ID: 10882245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from mammographic-histopathologic correlation of large-core needle breast biopsy.
    Berg WA; Hruban RH; Kumar D; Singh HR; Brem RF; Gatewood OM
    Radiographics; 1996 Sep; 16(5):1111-30. PubMed ID: 8888394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stereotactic Mammotome breast biopsy: routine clinical experience and correlation with BI-RADS--classification and histopathology].
    Michel SC; Löw R; Singer G; Otto R; Hohl M; Kubik RA
    Praxis (Bern 1994); 2007 Sep; 96(39):1459-74. PubMed ID: 17966279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.